139 related articles for article (PubMed ID: 34537396)
1. Commentary on "Mucormycosis co-infection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum" (Int J Surg 2021, 92:106031) - A pulmonary perspective.
Gangakhedkar MR; Gupta R
Int J Surg; 2021 Oct; 94():106116. PubMed ID: 34537396
[No Abstract] [Full Text] [Related]
2. Fostering a deeper understanding of COVID-19-associated mucormycosis - A commentary on "The mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum" (Int. J. Surg. 2021:106031).
MohanaSundaram A; Sathanantham ST; Chinchole V; Patil B; Velayutham R
Int J Surg; 2021 Oct; 94():106110. PubMed ID: 34534704
[No Abstract] [Full Text] [Related]
3. Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum.
Devnath P; Dhama K; Tareq AM; Emran TB
Int J Surg; 2021 Aug; 92():106031. PubMed ID: 34311126
[No Abstract] [Full Text] [Related]
4. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
[TBL] [Abstract][Full Text] [Related]
5. [Mucormycosis in the time of COVID-19: risks and challenges].
Seidel D; Sal E; Nacov JA; Cornely OA; Kurzai O
Dtsch Med Wochenschr; 2024 May; 149(10):569-578. PubMed ID: 38657596
[TBL] [Abstract][Full Text] [Related]
6. A systematic review on SARS-CoV-2-associated fungal coinfections.
Soni S; Namdeo Pudake R; Jain U; Chauhan N
J Med Virol; 2022 Jan; 94(1):99-109. PubMed ID: 34570905
[TBL] [Abstract][Full Text] [Related]
7. Mucormycosis: An unanticipated progeny of COVID-19.
Shrestha GS; Bhandari S; Lamsal R; Gurung U
JNMA J Nepal Med Assoc; 2021 Sep; 59(241):965-967. PubMed ID: 35199723
[TBL] [Abstract][Full Text] [Related]
8. Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review.
Sharma B; Nonzom S
Curr Microbiol; 2023 Aug; 80(10):322. PubMed ID: 37592083
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-associated mucormycosis: an epidemic within a pandemic.
Sarda R; Swain S; Ray A; Wig N
QJM; 2021 Oct; 114(6):355-356. PubMed ID: 34109406
[No Abstract] [Full Text] [Related]
10. Mucormycosis-A serious threat in the COVID-19 pandemic?
Szarpak L; Chirico F; Pruc M; Szarpak L; Dzieciatkowski T; Rafique Z
J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 34029629
[No Abstract] [Full Text] [Related]
11. Mixed Aspergillosis and Mucormycosis Infections in Patients with COVID-19: Case Series and Literature Review.
Sasani E; Pakdel F; Khodavaisy S; Salehi M; Salami A; Sohrabi M; Aminishakiba P; Amirafzali I; Salami Khaneshan A
Mycopathologia; 2024 Jan; 189(1):10. PubMed ID: 38231407
[TBL] [Abstract][Full Text] [Related]
12. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19.
Dallalzadeh LO; Ozzello DJ; Liu CY; Kikkawa DO; Korn BS
Orbit; 2022 Oct; 41(5):616-619. PubMed ID: 33752571
[TBL] [Abstract][Full Text] [Related]
13. Clinical-epidemiological Profile of Coronavirus Disease 19 Associated Mucomycosis (CAM) and Relation with Zinc and Iron Levels.
Karoli R; Kulshreshtha MR; Gupta N; Singh M; Singh V; Shakya S
J Assoc Physicians India; 2022 Feb; 70(2):11-12. PubMed ID: 35436818
[TBL] [Abstract][Full Text] [Related]
14. [Pediatric rhino-orbital mucormycosis. First peruvian case in times of the COVID-19 pandemic].
Meregildo-Rodriguez ED; Espino-Saavedra WG
Rev Peru Med Exp Salud Publica; 2021; 38(3):472-473. PubMed ID: 34932752
[No Abstract] [Full Text] [Related]
15. [Fungal infections in the COVID-19 pandemic, the case of mucormycosis].
Fernández NB
Rev Argent Microbiol; 2021; 53(3):181-182. PubMed ID: 34579807
[No Abstract] [Full Text] [Related]
16. Five probable factors responsible for the COVID-associated mucormycosis outbreak in India.
Ravindra K; Ahlawat A
Int J Infect Dis; 2021 Nov; 112():278-280. PubMed ID: 34592439
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
[TBL] [Abstract][Full Text] [Related]
18. Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.
Kamrul-Hasan AB; Selim S
Mymensingh Med J; 2021 Jul; 30(3):874-880. PubMed ID: 34226483
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 associated mucormycosis - An emerging threat.
Chao CM; Lai CC; Yu WL
J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
[TBL] [Abstract][Full Text] [Related]
20. In-hospital prevalence of mucormycosis among coronavirus disease 2019 (COVID-19) patients and COVID-19 in mucormycosis: a systematic review and meta-analysis.
Sinha A; Bhaskar SMM
Int Forum Allergy Rhinol; 2022 Mar; 12(3):313-317. PubMed ID: 34633150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
